Tech Company Financing Transactions
Biobot Surgical Funding Round
Biobot Surgical, operating out of Singapore, secured $24 million from private investors and Zig Capital.
Transaction Overview
Company Name
Announced On
3/8/2024
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Series B
Investors
private investors (Lead Investor) (Tony Tan)
Proceeds Purpose
The company intends to use the funds to expand its presence worldwide and further develop its digital surgery infrastructure.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
79 Ayer Rajah Crescent 04-05
Singapore, 139955
Singapore
Singapore, 139955
Singapore
Phone
Website
Email Address
Overview
At Biobot Surgical, our mission is to revolutionize the realm of robotic-assisted biopsy and treatment for prostate cancer. As the landscape for prostate cancer treatment evolves, we aren't just riding this wave of change -- we're propelling it, ushering in a new era of excellence in prostate disease management.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Sim Lak
Chief Executive Officer
Albert Lee
Chief Operating Officer
Kee Hwee
Chief Technical Officer
Chen HongJun
VP - Sales
Drew Shaffer
Browse more venture capital transactions:
Prev: 3/8/2024: Cosmology venture capital transaction
Next: 3/8/2024: Neural Propulsion Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs